The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part II
Authors:
- Richard C. BeckerRBRichard C. Becker
- 1 June 2005
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 149 (6) , 977-983
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic PlaquesCirculation, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient MiceMolecular Cell, 1998
- Roles of Infectious Agents in Atherosclerosis and RestenosisCirculation, 1997
- Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died SuddenlyNew England Journal of Medicine, 1997
- Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the MoonNew England Journal of Medicine, 1997
- Stability and Instability: Two Faces of Coronary AtherosclerosisCirculation, 1996
- Coronary Plaque DisruptionCirculation, 1995
- Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.Circulation, 1994
- Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.Circulation, 1994